{"title":"Applicability of the SENS-IS assay to assess skin sensitization of medical devices according the technical specification ISO/TS11796","authors":"Françoise Cottrez , Elodie Boitel , Essia Sahli , Christian Pellevoisin , Hervé Groux","doi":"10.1016/j.tiv.2025.106032","DOIUrl":null,"url":null,"abstract":"<div><div>Assessing skin sensitization is critical in the development of medical devices, and the SENS-IS assay provides a reliable <em>in vitro</em> alternative to traditional animal models. By utilizing reconstructed human epidermis (RHE), which closely mimics human skin, the assay allows testing with both saline and sesame oil under conditions similar to <em>in vivo</em> models, facilitating a smoother transition to non-animal testing. This study evaluated the efficacy of the SENS-IS assay according to ISO/TS 11796, testing 14 sensitizers and 3 non-sensitizers during the prevalidation phase, as well as the 8 sensitizers and 4 non-sensitizers recommended in an interlaboratory study using MED-2000 silicone extracts spiked with ISO-specified chemicals at LLNA EC3 concentrations.</div><div>The assay successfully identified 20 out of 22 sensitizers tested at EC3 concentrations. Two chemicals, poorly soluble in the vehicles used,—TPO (EC3 = 27) and Isopropyl Myristate (EC3 = 44)—were detected at slightly higher concentrations, with TPO detected at 50 % and Isopropyl Myristate at 75 % of their EC3 values. All 7 non-sensitizers were accurately classified. These results confirm the sensitivity of the SENS-IS assay and underscore its potential for medical device development, advancing the use of non-animal testing methods.</div></div>","PeriodicalId":54423,"journal":{"name":"Toxicology in Vitro","volume":"105 ","pages":"Article 106032"},"PeriodicalIF":2.6000,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Toxicology in Vitro","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0887233325000268","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"TOXICOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Assessing skin sensitization is critical in the development of medical devices, and the SENS-IS assay provides a reliable in vitro alternative to traditional animal models. By utilizing reconstructed human epidermis (RHE), which closely mimics human skin, the assay allows testing with both saline and sesame oil under conditions similar to in vivo models, facilitating a smoother transition to non-animal testing. This study evaluated the efficacy of the SENS-IS assay according to ISO/TS 11796, testing 14 sensitizers and 3 non-sensitizers during the prevalidation phase, as well as the 8 sensitizers and 4 non-sensitizers recommended in an interlaboratory study using MED-2000 silicone extracts spiked with ISO-specified chemicals at LLNA EC3 concentrations.
The assay successfully identified 20 out of 22 sensitizers tested at EC3 concentrations. Two chemicals, poorly soluble in the vehicles used,—TPO (EC3 = 27) and Isopropyl Myristate (EC3 = 44)—were detected at slightly higher concentrations, with TPO detected at 50 % and Isopropyl Myristate at 75 % of their EC3 values. All 7 non-sensitizers were accurately classified. These results confirm the sensitivity of the SENS-IS assay and underscore its potential for medical device development, advancing the use of non-animal testing methods.
期刊介绍:
Toxicology in Vitro publishes original research papers and reviews on the application and use of in vitro systems for assessing or predicting the toxic effects of chemicals and elucidating their mechanisms of action. These in vitro techniques include utilizing cell or tissue cultures, isolated cells, tissue slices, subcellular fractions, transgenic cell cultures, and cells from transgenic organisms, as well as in silico modelling. The Journal will focus on investigations that involve the development and validation of new in vitro methods, e.g. for prediction of toxic effects based on traditional and in silico modelling; on the use of methods in high-throughput toxicology and pharmacology; elucidation of mechanisms of toxic action; the application of genomics, transcriptomics and proteomics in toxicology, as well as on comparative studies that characterise the relationship between in vitro and in vivo findings. The Journal strongly encourages the submission of manuscripts that focus on the development of in vitro methods, their practical applications and regulatory use (e.g. in the areas of food components cosmetics, pharmaceuticals, pesticides, and industrial chemicals). Toxicology in Vitro discourages papers that record reporting on toxicological effects from materials, such as plant extracts or herbal medicines, that have not been chemically characterized.